Galectin Therapeutics (GALT) Share-based Compensation (2010 - 2026)
Galectin Therapeutics (GALT) recorded Share-based Compensation of $963,000 in Q2 2026, up 92.6% from $500,000 a year earlier and up 40.4% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Galectin Therapeutics' Share-based Compensation came in at $2.34 million as of Jun 30, 2026, up 12.9% year-over-year; for FY2025, it came in at $1.66 million, down 32.2% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $2.45 million in FY2024 (+8.2%), $2.26 million in FY2023 (-21.1%), $2.87 million in FY2022 (+38.1%) and $2.08 million in FY2021 (+15.4%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation since Q4 2018.
- On a year-over-year basis, Share-based Compensation rose in three of the last eight quarters, with growth averaging 2.5%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 237.8% in Q1 2022, against a decline of 66.9% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $686,000 (Q1 2026), $195,000 (Q4 2025) and $496,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - | 963,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 963,000.00 |
| Mar 31, 2026 | 775,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Sep 30, 2025 | 498,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | 515,000.00 |
| Jun 30, 2024 | 738,000.00 |
| Mar 31, 2024 | 604,000.00 |
| Dec 31, 2023 | 405,000.00 |
| Sep 30, 2023 | 586,000.00 |
| Jun 30, 2023 | 516,000.00 |
| Mar 31, 2023 | 662,000.00 |
| Dec 31, 2022 | 681,000.00 |
| Sep 30, 2022 | 681,000.00 |
| Jun 30, 2022 | 647,000.00 |
| Mar 31, 2022 | 858,000.00 |
| Dec 31, 2021 | 654,000.00 |
| Sep 30, 2021 | 587,000.00 |
API Access
Galectin Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();